$TBLA Balance Sheet | Understand Stock

$TBLA

$3.39 +$0.01 (0.3%) Close

$TBLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated interim balance sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
CURRENT ASSETS
Cash and cash equivalents
Short-term investments
Restricted deposits
Trade receivables (net of allowance for credit losses of $15,227 and $13,889 as of June 30, 2026 and December 31, 2025, respectively) (1)
Prepaid expenses and other current assets
Total current assets
NON-CURRENT ASSETS
Long-term prepaid expenses
Commercial agreement asset
Restricted deposits
Deferred tax assets, net
Operating lease right of use assets
Property and equipment, net
Intangible assets, net
Goodwill
Total non-current assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES
Trade payables
Short-term operating lease liabilities
Accrued expenses and other current liabilities
Current maturities of long-term loan
Total current liabilities
LONG-TERM LIABILITIES
Long-term loan, net of current maturities
Long-term loan and revolving credit facility (3)
Long-term operating lease liabilities
Warrants liability
Deferred tax liabilities, net
Other long-term liabilities
Total long-term liabilities
Preferred A, B, B-1, B-2, C, D and E shares with no par value - Authorized: 0 and 123,389,750 shares as of December 31, 2021 and 2020, respectively; Issued and outstanding: 0 and 121,472,152 shares as of December 31, 2021 and 2020, respectively.
Authorized share capital (in shares)
Ordinary shares
Non-voting Ordinary shares
Total authorized share capital (in shares)
Common stock, shares issued (in shares)
Ordinary shares
Non-voting Ordinary shares
Total common stock, shares issued (in shares)
Common stock, shares outstanding (in shares)
Ordinary shares
Non-voting Ordinary shares
Total common stock, shares outstanding (in shares)
SHAREHOLDERS' EQUITY
Ordinary shares
Ordinary shares
Non-voting Ordinary shares
Total ordinary shares
Treasury Ordinary shares, at cost - 126,683,068 (111,524,010 Ordinary shares and 15,159,058 Non-voting Ordinary shares) and 110,438,588 (95,279,530 Ordinary shares and 15,159,058 Non-voting Ordinary shares) as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Treasury stock, common (in shares)
Ordinary shares
Non-voting Ordinary shares
Total treasury stock, common (in shares)

Comments